COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cell phone, according to Rice University engineers.
Feb 25, 2021
0
40
Baby mice might be small, but they're tough, too. For their first seven days of life, they have the special ability to regenerate damaged heart tissue. Humans, on the other hand, aren't so lucky: any heart injuries we suffer ...
Feb 25, 2021
0
85
Researchers in the Cockrell School of Engineering at The University of Texas at Austin have developed the first large-scale in vivo drug discovery platform using a whole animal model that could speed up scientific research ...
Oct 11, 2016
0
0
When testing a new medicine, researchers must do more than assess how well that drug works. They also have to determine whether the medicine has some negative, unintended consequences.
Feb 22, 2024
0
9
The Terasaki Institute for Biomedical Innovation (TIBI) has developed a novel organ-on-a-chip device for measuring electrical resistance across endothelial barriers. This chip had carbon-based, screen-printed electrodes incorporated ...
Oct 25, 2023
0
0
Hepatitis C affects more than 354 million people worldwide. About 75 to 85 percent of people who have it get a long-term infection referred to as chronic Hepatitis C. Left untreated, it could lead to cirrhosis, liver cancer ...
Aug 4, 2022
0
9
It usually takes 10 to 15 years to develop a new drug, and they cost around US$2.6 billion each. Because it's difficult to predict how a drug candidate will interact with human cells, many drugs never pass clinical trials. ...
Jul 27, 2021
0
18
Scientists at EPFL are using technology to better understand how coronavirus causes blood clots in some patients. They have developed a simplified model of a lung that lets them observe, for the first time, how the virus ...
Oct 7, 2020
0
9
Engineers have used microfluidic technology to create a "placenta-on-a-chip" that models how compounds can be passed from a mother to a fetus.
Feb 19, 2019
0
4
NIBIB-funded researchers have created a novel, low-cost biosensor to detect HER-2, a breast cancer biomarker in the blood, allowing for a far less invasive diagnostic test than the current practice, a needle biopsy. Scientists ...
Dec 10, 2018
0
3
